Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$16.7M Buy
171,720
+22,507
+15% +$2.06M 0.08% 226
2025
Q4
$13.2M Sell
149,213
-40,019
-21% -$3.64M 0.07% 255
2025
Q3
$12.2M Buy
189,232
+27,568
+17% +$2.23M 0.08% 235
2025
Q2
$12.3M Buy
161,664
+147,099
+1,010% +$10.9M 0.09% 211
2025
Q1
$1.02M Buy
14,565
+1,667
+13% +$130K 0.01% 822
2024
Q4
$1.13M Buy
12,898
+8,736
+210% +$765K 0.01% 721
2024
Q3
$348K Buy
+4,162
New +$333K 0.01% 1035

Other funds holding SRE

&Partners's SRE Position: Q1 2026 in Review

&Partners increased its Sempra (SRE) stake by 15% in Q1 2026, buying an estimated $2.06M and bringing the position to 171,720 shares worth $16.7M. The position accounts for 0.08% of the portfolio, ranked #226.

&Partners first reported a position in SRE in Q3 2024 and has held it in 7 quarters since. 1,264 funds tracked by Wall St. Rank hold SRE as of Q1 2026.

  • &Partners held 171,720 shares of Sempra worth $16.7M as of Q1 2026.
  • &Partners bought 22,507 Sempra shares in Q1 2026, an estimated $2.06M.
  • Sempra made up 0.08% of &Partners's portfolio in Q1 2026, its #226 holding.
  • &Partners first reported a position in Sempra in Q3 2024 and has held it in 7 quarters since.
  • 1,264 funds tracked by Wall St. Rank held Sempra as of Q1 2026.

Based on &Partners's 13F filing for Q1 2026, filed 15 May 2026.